FamiCord AG (VTIAF)
OTC Markets OTCPK · USD · Healthcare · Medical Care Facilities
$3.10 (+0.00%) as of
Key statistics
- Market cap
- 54.04M
- EPS (TTM)
- -0.4300
- Dividend yield
- 0.00%
- 52-week range
- 3.1000 – 7.0000
- Beta
- 0.64
- Revenue (TTM)
- 87.78M
- Profit margin
- -8.57%
- Volume
- 2.00
About FamiCord AG
FamiCord AG engages in the collection, processing, storage, and distribution of cells, tissues, blood, and blood components for medical applications in Germany, Poland, Switzerland, Portugal, and internationally. The company operates through Subgroup Vita 34 And Subgroup PBKM segments. It produces and develops advanced therapies, genetic tests, and analyses for third parties. The company also engages in the development and manufacture of cell and tissue-based products and pharmaceuticals, including the production of viral vectors or comparable products. In addition, it engages in research and development, storage, and cryopreservation of sperm and oocytes for use in reproductive medicine; and the manufacturing and distribution of medical devices. The company was formerly known as VITA 34 AG and changed its name to FamiCord AG in February 2025. FamiCord AG was founded in 1997 and is headquartered in Leipzig, Germany.
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Headquarters
- Leipzig, Germany
- Employees
- 625
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.